The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on substance use disorder treatment. A recent report from the National Academies of Sciences, Engineering and Medicine highlighted the dearth of clinicians with specialized training in Medication Assisted Treatment, and the Substance Abuse and Mental Health Services Administration has estimated that only 10% of the 22 million Americans with a SUD receive treatment. “Your legislation would address these shortages by providing 1,000 additional Medicare-funded residency positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in letters of support to the bills’ sponsors. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.”
The Montana legislature last week passed legislation funding Medicaid coverage for low-income adults for six more years.
The AHA and American Association for Physician Leadership today released Leadership Evolve, a collection of digital resources on dyad leadership and workforce…
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the…
April 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Insights and Analysis
Learn how an Oregon association collaborated with community stakeholders to produce an evidence-based toolkit to prevent workplace violence.
There is no doubt that enhanced convenience and customer service is where health care is headed.